Day 4 ASCO 2021 Roundup: Immunotherapy Candidates Show Promise in Early Studies
The fourth day of the ASCO 2021 virtual annual meeting featured clinical trial data of some promising immunotherapy candidates. Oncolytic Viral Therapy Shows Promising Results in Fighting T-cell Lymphoma Joselle …
Read More